Evaluation of supplementary carnosine accumulation and distribution: an initial analysis of participants in the Nucleophilic Defense Against PM Toxicity (NEAT) clinical trial.
- 2024-08-31
- RCT
- Amino acids 56(1)
- Shahid P Baba
- Alok R Amraotkar
- David Hoetker
- Hong Gao
- Daniel Gomes
- Jingjing Zhao
- Michael F Wempe
- Peter J Rice
- Andrew P DeFilippis
- Shesh N Rai
- C Arden Pope
- Aruni Bhatnagar
- Timothy E O'Toole
- PubMed: 39215872
- DOI: 10.1007/s00726-024-03414-5
- High evidence
No adverse reactions were reported by those in the carnosine or placebo arms, nor did carnosine supplementation have any effect on kidney, liver, and cardiac function or blood electrolytes.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 2 g/day